A Phase 1 interventional study of Rosuvastatin (5mg, 20mg, 40mg) and Atorvastatin (10mg, 20mg, 40mg) in Lipid Profile,Blood Pressure, sponsored by Shaheed Benazir Bhutto University Sheringal Dir Upper. Not yet recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-05.
Sponsored by Shaheed Benazir Bhutto University Sheringal Dir Upper · Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study is a Phase I randomized clinical trial aiming to investigate the short-term effects of three commonly prescribed statins i.e (Atorvastatin, Rosuvastatin, and Simvastatin) at different dose levels i.e lo,median and high doses on cardiovascular parameters i.e Blood pressure and ECG morphology in healthy volunteers. The study will assess changes in blood pressure and ECG morphology following two days of statin administration under controlled conditions.
The goal of this study is to evaluate the effects of these three statins on the cardiovascular parameters in a dose-dependent manner. In this Phase 1 clinical trial we will enroll healthy volunteers who will be randomized to receive one of three statins at low, moderate, or high doses for two days. .
Shaheed Benazir Bhutto University Sheringal Dir Upper is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
On an ECG, the QT interval is the time the heart’s lower chambers take to activate electrically and recover in each beat. QTc is that time adjusted for heart rate (QTcF by Fridericia’s formula, QTcB by Bazett’s). Some medicines lengthen it, and a long QTc can raise the risk of a dangerous heart rhythm.
The study may name a correction formula and a limit in milliseconds, often around 450–480.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
QT and QTc
On an ECG, the QT interval is the time the heart’s lower chambers take to activate electrically and recover in each beat. QTc is that time adjusted for heart rate (QTcF by Fridericia’s formula, QTcB by Bazett’s). Some medicines lengthen it, and a long QTc can raise the risk of a dangerous heart rhythm.
The study may name a correction formula and a limit in milliseconds, often around 450–480.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The assigned participants will be given Rosuvastatin 5mg, 20mg, 40mg OD for two days
Drug: Rosuvastatin (5mg, 20mg, 40mg)
The assigned participants will be given Atorvastatin 10mg,20mg, 40mg OD for two days
Drug: Atorvastatin (10mg, 20mg, 40mg)
The assigned participants will be given Simvastatin 10mg, 20mg, 40mg OD for two days
Drug: Simvastatin (10mg, 20mg, 40m
The Rosuvastatin (5mg, 20mg, 40mg) group participants will be given the drug orally OD for two days
The Atorvastatin (10mg, 20mg, 40mg) group participants will be given the drug orally OD for two days
The Simvastatin (10mg, 20mg, 40mg) group participants will be given the drug orally OD for two days
Blood Pressure Measurements
Blood Pressure of the subjects will be determined by sphygmomanometer
Time frame: before dosing and 2 days after dosing achieving peak plasma concentrations respectively]
Electrocardiograms (ECGs) Measurements
ECGs of the subjects will be determined by 12 Leads ECG Machine.QT interval and QRS complex in milliseconds will be analyzed to determine the effects of these statins on ECG morphology
Time frame: before dosing and 2 days after dosing achieving peak plasma concentrations respectively]
Plan to share: Yes — The study results will be shared in well reputable Journals without the participant identifiers
Supporting information: Clinical study report
No publications or documents are linked to this record.
Start is estimated for Mar 2026; primary completion for Dec 2026, 9 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Rosuvastatin · Atorvastatin · Simvastatin
Shaheed Benazir Bhutto University Sheringal Dir Upper